No Picture
Business News

Fed’s Powell says economy may face ‘extended period’ of weak growth

Federal Reserve Chair Jerome Powell, in a sober review of where the U.S. economy stands on the cusp of its reopening, said on Wednesday the country could face an “extended period” of weak growth and stagnant incomes, pledged to use more Fed power as needed, and issued a call for more fiscal spending.

…read more […]

No Picture
Business News

Instant view: Powell: Brace for ‘extended period’ of economic woe

Federal Reserve Chair Jerome Powell, in a sober review of where the U.S. economy stands on the cusp of its reopening, said on Wednesday the country could face an “extended period” of weak growth and stagnant incomes, pledged to use more Fed power as needed, and issued a call for more fiscal spending.

…read more […]

No Picture
Trading Ideas

U.S. Meat-Plant Changes Signal End of the 99-Cent Chicken

(Bloomberg) — The human cost of producing 99-cent chickens and affordable burgers during a pandemic is pushing U.S. meatpackers to eye major operational changes that will likely make American meat more costly.Some plants are already running slower than normal to adhere to social distancing. But companies are also considering how best to redesign their operations to prevent infections, including by automating some lines altogether. The likely result: higher costs for an industry dominated by the likes of Tyson Foods Inc. and JBS SA that’s been very efficient at pumping out cheap meat.The changes are arriving as concerns mount over mega-plants …read more […]

No Picture
Trading Ideas

CymaBay (CBAY) Stock Is up 127% in a Day. How Much Higher Can It Go?

Six months ago, disturbing liver biopsies suggesting some patients in an FDA Phase 2b study of CymaBay Therapeutics (CBAY) suffered inflamed and destroyed liver cells forced the company to suspend nonalcoholic steatohepatitis (NASH) treatment trials of its seladelpar liver treatment drug — and cost CymaBay stock 75% of its market cap. Six months later, a new study just showed no evidence that seladelpar causes liver damage, giving CymaBay the all-clear to proceed with its trials, and more than doubling the stock’s share price on Tuesday.Analysts rushed to hail the results, and as of today, every one of the six analysts …read more […]

No Picture
Business News

Mitsubishi slashes SpaceJet budget, drops variant

Mitsubishi Heavy Industries (MHI) said it was more than halving the annual development budget for its SpaceJet regional jet as the coronavirus pandemic squeezes profit, and will suspend plans for a possible variant seen as key to winning future orders, particularly from U.S. airlines.

…read more […]